ALVNF yields 35.71% · JNJ yields 2.13%● Live data
📍 ALVNF pulled ahead of the other in Year 1
Combined, ALVNF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALVNF + JNJ for your $10,000?
Alviva Holdings Limited provides information and communication technology (ICT) products and services in South Africa, rest of Africa, and internationally. It operates through three segments: ICT Distribution, Services and Solutions, and Financial Services. The ICT Distribution segment imports, assembles, distributes, and sells hardware and software products in sub-Saharan African markets through reseller channels and retail chains. The Services and Solutions segment provides systems integration and ICT solutions, including cybersecurity, application development, and artificial intelligence, as well as undertakes projects in the renewable energy. The Financial Services segment offers finance solutions to business entities in the SMME and commercial sectors. The company was formerly known as Pinnacle Holdings Limited and changed its name to Alviva Holdings Limited in March 2017. Alviva Holdings Limited was incorporated in 1986 and is based in Midrand, South Africa.
Full ALVNF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.